Haemonetics Corporation updated revenue guidance for the year 2023. For the period, The Company updated its previous fiscal 2023 GAAP total revenue growth guidance from 8% - 11% to 12% - 15% and its fiscal 2023 organic revenue growth guidance as follows: total revenue of 15% - 18% against previous guidance of 10% - 14%.